Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A7 CYP2A13	4.24e-07	3	151	3	GO:0008389
GeneOntologyMolecularFunction	alpha-glucosidase activity	SI AGL MGAM2	1.45e-05	7	151	3	GO:0090599
GeneOntologyMolecularFunction	steroid hydroxylase activity	CYP2A6 CYP2A7 CYP2A13 CYP2R1	1.22e-04	34	151	4	GO:0008395
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 DNAH10 DNAH1 DYNLRB1	1.71e-04	37	151	4	GO:0045505
GeneOntologyMolecularFunction	glucosidase activity	SI AGL MGAM2	1.80e-04	15	151	3	GO:0015926
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH10 DNAH1	3.18e-04	18	151	3	GO:0008569
GeneOntologyMolecularFunction	histone methyltransferase binding	NOP56 LCORL LCOR	3.18e-04	18	151	3	GO:1990226
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	CYP2A6 CYP2A7 CYP2A13 CYP2R1	5.11e-04	49	151	4	GO:0016712
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	SI MGAM2	5.60e-04	5	151	2	GO:0004558
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP2A6 CYP2A7 CYP2A13	7.64e-04	24	151	3	GO:0008392
GeneOntologyMolecularFunction	extracellular matrix protein binding	ITGAV ITGB8	8.35e-04	6	151	2	GO:1990430
GeneOntologyMolecularFunction	arachidonate monooxygenase activity	CYP2A6 CYP2A7 CYP2A13	1.09e-03	27	151	3	GO:0008391
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 DNAH10 DNAH1	1.21e-03	28	151	3	GO:0051959
GeneOntologyBiologicalProcess	cellular process involved in reproduction in multicellular organism	CFAP47 FOXO3 DNHD1 FNDC3A PRAMEF17 DCST1 DNAH1 ACTL7A KMT2D FBXO5 BRCA2 PDILT GALNTL5 VPS13B	3.18e-05	527	150	14	GO:0022412
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	CYP2A6 CYP2A7 CYP2A13	4.36e-05	10	150	3	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	CYP2A6 CYP2A7 CYP2A13	4.36e-05	10	150	3	GO:0009804
GeneOntologyBiologicalProcess	germ cell development	CFAP47 FOXO3 DNHD1 FNDC3A PRAMEF17 DNAH1 ACTL7A KMT2D FBXO5 BRCA2 PDILT GALNTL5 VPS13B	5.27e-05	482	150	13	GO:0007281
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH10 DNAI3 DNAH1	5.31e-07	10	151	4	GO:0036156
GeneOntologyCellularComponent	axonemal dynein complex	DNHD1 DNAH10 DNAI3 DNAH1	2.94e-05	25	151	4	GO:0005858
GeneOntologyCellularComponent	dynein complex	DNHD1 DNAH10 DNAI3 DNAH1 DYNLRB1	4.38e-05	54	151	5	GO:0030286
GeneOntologyCellularComponent	integrin alphav-beta8 complex	ITGAV ITGB8	5.18e-05	2	151	2	GO:0034686
GeneOntologyCellularComponent	cone photoreceptor outer segment	TMEM237 PRKCA CNGA3	5.84e-05	11	151	3	GO:0120199
GeneOntologyCellularComponent	alphav-beta3 integrin-PKCalpha complex	ITGAV PRKCA	1.55e-04	3	151	2	GO:0035866
GeneOntologyCellularComponent	cytoplasmic microtubule	CYP2A6 CYP2A7 CYP2A13 TOGARAM1 FAM161A NIN	4.15e-04	133	151	6	GO:0005881
GeneOntologyCellularComponent	spindle	TOPBP1 PTP4A1 CEP350 PARP4 LATS1 FBXO5 FAM161A HECW2 HSF1 SKA1 NIN	6.42e-04	471	151	11	GO:0005819
HumanPheno	Irregularly shaped sperm tail	CFAP47 DNHD1 DNAH10 DNAH1	1.04e-05	15	50	4	HP:0033393
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A7 CYP2A13	1.98e-06	4	149	3	IPR008067
Domain	HTH_psq	LCORL LCOR	6.32e-05	2	149	2	PF05225
Domain	Dynein_HC_stalk	DNHD1 DNAH10 DNAH1	1.70e-04	14	149	3	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH10 DNAH1	1.70e-04	14	149	3	IPR013602
Domain	DHC_N2	DNHD1 DNAH10 DNAH1	1.70e-04	14	149	3	PF08393
Domain	MT	DNHD1 DNAH10 DNAH1	1.70e-04	14	149	3	PF12777
Domain	DHC_fam	DNHD1 DNAH10 DNAH1	2.11e-04	15	149	3	IPR026983
Domain	Dynein_heavy	DNHD1 DNAH10 DNAH1	2.11e-04	15	149	3	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH10 DNAH1	2.11e-04	15	149	3	IPR004273
Domain	Gal_mutarotase_N	SI MGAM2	3.75e-04	4	149	2	IPR031727
Domain	NtCtMGAM_N	SI MGAM2	3.75e-04	4	149	2	PF16863
Domain	BRCT	TOPBP1 PARP4 TP53BP1	4.39e-04	19	149	3	PF00533
Domain	Cyt_P450_E_grp-I	CYP2A6 CYP2A7 CYP2A13 CYP2R1	4.50e-04	45	149	4	IPR002401
Domain	FYrich_C	KMT2C KMT2D	6.22e-04	5	149	2	IPR003889
Domain	FYrich_N	KMT2C KMT2D	6.22e-04	5	149	2	IPR003888
Domain	FYRC	KMT2C KMT2D	6.22e-04	5	149	2	SM00542
Domain	FYRN	KMT2C KMT2D	6.22e-04	5	149	2	SM00541
Domain	Autophagy-rel_C	ATG2A VPS13B	6.22e-04	5	149	2	IPR015412
Domain	ATG_C	ATG2A VPS13B	6.22e-04	5	149	2	PF09333
Domain	FYRN	KMT2C KMT2D	6.22e-04	5	149	2	PF05964
Domain	FYRC	KMT2C KMT2D	6.22e-04	5	149	2	PF05965
Domain	FYRC	KMT2C KMT2D	6.22e-04	5	149	2	PS51543
Domain	FYRN	KMT2C KMT2D	6.22e-04	5	149	2	PS51542
Domain	BRCT	TOPBP1 PARP4 TP53BP1	6.86e-04	22	149	3	SM00292
Domain	-	TOPBP1 PARP4 TP53BP1	7.84e-04	23	149	3	3.40.50.10190
Domain	Cyt_P450_CS	CYP2A6 CYP2A7 CYP2A13 CYP2R1	8.41e-04	53	149	4	IPR017972
Domain	Glyco_hydro_31_AS	SI MGAM2	9.29e-04	6	149	2	IPR030458
Domain	Lipase_euk	LIPJ LIPA	9.29e-04	6	149	2	IPR025483
Domain	Abhydro_lipase	LIPJ LIPA	9.29e-04	6	149	2	PF04083
Domain	AB_hydrolase_lipase	LIPJ LIPA	9.29e-04	6	149	2	IPR006693
Domain	PH_12	PLCH2 PLCL2	9.29e-04	6	149	2	PF16457
Domain	CYTOCHROME_P450	CYP2A6 CYP2A7 CYP2A13 CYP2R1	1.11e-03	57	149	4	PS00086
Domain	BRCT	TOPBP1 PARP4 TP53BP1	1.13e-03	26	149	3	PS50172
Domain	LIPASE_SER	LIPJ LIPA PGAP1	1.13e-03	26	149	3	PS00120
Domain	-	CYP2A6 CYP2A7 CYP2A13 CYP2R1	1.18e-03	58	149	4	1.10.630.10
Domain	p450	CYP2A6 CYP2A7 CYP2A13 CYP2R1	1.18e-03	58	149	4	PF00067
Domain	Glyco_hydro_31	SI MGAM2	1.29e-03	7	149	2	IPR000322
Domain	Glyco_hydro_31	SI MGAM2	1.29e-03	7	149	2	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	SI MGAM2	1.29e-03	7	149	2	PS00129
Domain	Cyt_P450	CYP2A6 CYP2A7 CYP2A13 CYP2R1	1.34e-03	60	149	4	IPR001128
Domain	BRCT_dom	TOPBP1 PARP4 TP53BP1	1.41e-03	28	149	3	IPR001357
Domain	Chorein_N	ATG2A VPS13B	1.72e-03	8	149	2	PF12624
Domain	VPS13_N	ATG2A VPS13B	1.72e-03	8	149	2	IPR026854
Domain	Trefoil	SI MGAM2	1.72e-03	8	149	2	PF00088
Domain	P_TREFOIL_2	SI MGAM2	2.19e-03	9	149	2	PS51448
Domain	PD	SI MGAM2	2.19e-03	9	149	2	SM00018
Domain	Na_channel_asu	SCN7A SCN10A	2.73e-03	10	149	2	IPR001696
Domain	Na_trans_assoc	SCN7A SCN10A	2.73e-03	10	149	2	IPR010526
Domain	Na_trans_assoc	SCN7A SCN10A	2.73e-03	10	149	2	PF06512
Domain	Pkinase_C	LATS1 PRKCA ROCK1	3.17e-03	37	149	3	IPR017892
Domain	-	SI MGAM2	3.32e-03	11	149	2	4.10.110.10
Domain	P_trefoil_dom	SI MGAM2	3.96e-03	12	149	2	IPR000519
Domain	HTH_Psq	LCORL LCOR	3.96e-03	12	149	2	IPR007889
Domain	HTH_PSQ	LCORL LCOR	3.96e-03	12	149	2	PS50960
Domain	Pkinase_C	LATS1 PRKCA ROCK1	4.55e-03	42	149	3	PF00433
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH1	5.40e-03	14	149	2	IPR024317
Domain	ATPase_dyneun-rel_AAA	DNAH10 DNAH1	5.40e-03	14	149	2	IPR011704
Domain	SEA	MUC16 ADGRF5	5.40e-03	14	149	2	SM00200
Domain	AAA_8	DNAH10 DNAH1	5.40e-03	14	149	2	PF12780
Domain	AAA_5	DNAH10 DNAH1	5.40e-03	14	149	2	PF07728
Domain	EF-hand_like	PLCH2 PLCL2	6.20e-03	15	149	2	PF09279
Domain	-	MUC16 ADGRF5	6.20e-03	15	149	2	3.30.70.960
Domain	PI-PLC-Y	PLCH2 PLCL2	6.20e-03	15	149	2	PF00387
Domain	PLCYc	PLCH2 PLCL2	6.20e-03	15	149	2	SM00149
Domain	PLipase_C_Pinositol-sp_Y	PLCH2 PLCL2	6.20e-03	15	149	2	IPR001711
Domain	PIPLC_Y_DOMAIN	PLCH2 PLCL2	6.20e-03	15	149	2	PS50008
Domain	PI-PLC_fam	PLCH2 PLCL2	6.20e-03	15	149	2	IPR001192
Domain	PLC_EF-hand-like	PLCH2 PLCL2	6.20e-03	15	149	2	IPR015359
Domain	Post-SET_dom	KMT2C KMT2D	7.05e-03	16	149	2	IPR003616
Domain	PostSET	KMT2C KMT2D	7.05e-03	16	149	2	SM00508
Domain	POST_SET	KMT2C KMT2D	7.05e-03	16	149	2	PS50868
Domain	Gal_mutarotase_SF_dom	SI MGAM2	7.95e-03	17	149	2	IPR011013
Pubmed	Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	31645370
Pubmed	A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	8297477
Pubmed	Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	8188299
Pubmed	Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	8250953
Pubmed	The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	2703500
Pubmed	Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	22217847
Pubmed	Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	22890016
Pubmed	Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	3346244
Pubmed	Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	2733794
Pubmed	Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	8484736
Pubmed	Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	1417950
Pubmed	Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	24045421
Pubmed	Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	32987105
Pubmed	Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	2765478
Pubmed	Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation.	CYP2A6 CYP2A7 CYP2A13	8.18e-08	3	152	3	2415518
Pubmed	Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.	CYP2A6 CYP2A7 CYP2A13	3.26e-07	4	152	3	10490589
Pubmed	Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice.	CYP2A6 CYP2A7 CYP2A13	3.26e-07	4	152	3	1970547
Pubmed	Transcriptional regulation by HNF-4 of the steroid 15alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver.	CYP2A6 CYP2A7 CYP2A13	3.26e-07	4	152	3	9408084
Pubmed	A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.	CYP2A6 CYP2A7 CYP2A13	3.26e-07	4	152	3	7565685
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 ABCA2 TOPBP1 FNDC3A ATG2A VANGL2 KMT2C HECW2 PLCH2 EDEM1 LCOR CNOT1 NIN	6.45e-07	529	152	13	14621295
Pubmed	A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.	CYP2A6 CYP2A7 CYP2A13	1.62e-06	6	152	3	7668294
Pubmed	Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19.	CYP2A6 CYP2A7 CYP2A13	1.62e-06	6	152	3	8587134
Pubmed	Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.	CYP2A6 CYP2A7 CYP2A13	2.83e-06	7	152	3	9630227
Pubmed	Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster.	CYP2A6 CYP2A7 CYP2A13	2.83e-06	7	152	3	14630516
Pubmed	Genetic correction of PSA values using sequence variants associated with PSA levels.	TBX3 HNF1B TERT	2.83e-06	7	152	3	21160077
Pubmed	ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.	DNHD1 BRCA2 LCOR TP53BP1	5.69e-06	27	152	4	17525332
Pubmed	DEFOG: a practical scheme for deciphering families of genes.	OR8J3 OR2M2 OR5B2 OR8J1 OR1D4 OR5AL1 OR1D5 OR2AG1	5.86e-06	219	152	8	12213199
Pubmed	Maternal DHA intake in mice increased DHA metabolites in the pup brain and ameliorated MeHg-induced behavioral disorder.	CYP2A6 CYP2A7 CYP2A13	6.74e-06	9	152	3	37838304
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TET2 SUPT20H ERF LCORL SRF ZNF217 KMT2C KMT2D ROCK1 LCOR	1.09e-05	398	152	10	35016035
Pubmed	Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.	TOPBP1 PRKCA ROCK1 NIN	1.15e-05	32	152	4	20056645
Pubmed	Human transcription factor protein interaction networks.	TET2 HNF1B SUPT20H TCF12 ERF NOP56 DNAH10 RPN1 DTNA ZNF217 ZBTB1 DDX27 KMT2C KMT2D GTF3C1 DCP1B SEC24B CNOT1 TP53BP1	1.64e-05	1429	152	19	35140242
Pubmed	Effect of integrin AV and B8 gene polymorphisms in patients with traumatic brain injury.	ITGAV ITGB8	1.90e-05	2	152	2	31033358
Pubmed	Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy.	ITGAV ITGB8	1.90e-05	2	152	2	34233193
Pubmed	Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.	CYP2A6 CYP2A7	1.90e-05	2	152	2	12325023
Pubmed	Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.	CYP2A6 CYP2A13	1.90e-05	2	152	2	30876690
Pubmed	CYP2A5 induction and hepatocellular stress: an adaptive response to perturbations of heme homeostasis.	CYP2A6 CYP2A13	1.90e-05	2	152	2	21395539
Pubmed	Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice.	ITGAV ITGB8	1.90e-05	2	152	2	21099117
Pubmed	Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.	CYP2A6 CYP2A13	1.90e-05	2	152	2	12162851
Pubmed	Molecular characterization of the murine Coh locus: an amino acid difference at position 117 confers high and low coumarin 7-hydroxylase activity in P450coh.	CYP2A6 CYP2A13	1.90e-05	2	152	2	1302041
Pubmed	Structural alteration of mouse P450coh by mutation of glycine-207 to proline: spin equilibrium, enzyme kinetics, and heat sensitivity.	CYP2A6 CYP2A13	1.90e-05	2	152	2	8395817
Pubmed	Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice.	CYP2A6 CYP2A13	1.90e-05	2	152	2	25804444
Pubmed	Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.	CYP2A6 CYP2A13	1.90e-05	2	152	2	1520280
Pubmed	Induction of apoptosis by L-NMMA, via FKHRL1/ROCK pathway in human gastric cancer cells.	FOXO3 ROCK1	1.90e-05	2	152	2	17044646
Pubmed	Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.	CYP2A6 CYP2A13	1.90e-05	2	152	2	23917075
Pubmed	CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.	CYP2A6 CYP2A7	1.90e-05	2	152	2	16636685
Pubmed	Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.	CYP2A6 CYP2A13	1.90e-05	2	152	2	27902773
Pubmed	General structural features that regulate integrin affinity revealed by atypical αVβ8.	ITGAV ITGB8	1.90e-05	2	152	2	31792290
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	1.90e-05	2	152	2	31924266
Pubmed	Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.	TET2 KMT2C	1.90e-05	2	152	2	26880370
Pubmed	Outfielders playing in the infield: functions of aging-associated "nuclear" proteins in the mitochondria.	FOXO3 TERT	1.90e-05	2	152	2	25470293
Pubmed	Ten-eleven translocation 2 interacts with forkhead box O3 and regulates adult neurogenesis.	FOXO3 TET2	1.90e-05	2	152	2	28660881
Pubmed	Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ.	CYP2A6 CYP2A13	1.90e-05	2	152	2	30154104
Pubmed	Expression of CYP2A genes in human liver and extrahepatic tissues.	CYP2A7 CYP2A13	1.90e-05	2	152	2	10353262
Pubmed	Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.	CYP2A6 CYP2A13	1.90e-05	2	152	2	21418183
Pubmed	Identification of the tumor‑suppressive role of circular RNA‑FOXO3 in colorectal cancer via regulation of miR‑543/LATS1 axis.	FOXO3 LATS1	1.90e-05	2	152	2	34549306
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	1.90e-05	2	152	2	28967912
Pubmed	Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity.	LEPR SCN10A	1.90e-05	2	152	2	25161883
Pubmed	Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.	CYP2A6 CYP2A13	1.90e-05	2	152	2	19923441
Pubmed	Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.	CYP2A6 CYP2A13	1.90e-05	2	152	2	12499123
Pubmed	Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.	CYP2A6 CYP2A13	1.90e-05	2	152	2	22497566
Pubmed	DNA methylation and FoxO3a regulate PHLPP1 expression in chondrocytes.	FOXO3 PHLPP1	1.90e-05	2	152	2	29775231
Pubmed	PKC-dependent regulation of Kv7.5 channels by the bronchoconstrictor histamine in human airway smooth muscle cells.	KCNQ5 PRKCA	1.90e-05	2	152	2	28283479
Pubmed	Identification and characterization of Mlr1,2: two mouse homologues of Mblk-1, a transcription factor from the honeybee brain(1).	LCORL LCOR	1.90e-05	2	152	2	12560079
Pubmed	Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.	KMT2C KMT2D	1.90e-05	2	152	2	36601880
Pubmed	The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.	CYP2A6 CYP2A13	1.90e-05	2	152	2	26363552
Pubmed	Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes.	CYP2A6 CYP2A13	1.90e-05	2	152	2	2712571
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	1.90e-05	2	152	2	28483418
Pubmed	VANGL2 interacts with integrin αv to regulate matrix metalloproteinase activity and cell adhesion to the extracellular matrix.	ITGAV VANGL2	1.90e-05	2	152	2	29097183
Pubmed	Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.	CYP2A6 CYP2A13	1.90e-05	2	152	2	22696418
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	1.90e-05	2	152	2	34156443
Pubmed	Phosphorylation-mediated interactions with TOPBP1 couple 53BP1 and 9-1-1 to control the G1 DNA damage checkpoint.	TOPBP1 TP53BP1	1.90e-05	2	152	2	31135337
Pubmed	Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.	CYP2A6 CYP2A13	1.90e-05	2	152	2	30222954
Pubmed	Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.	CYP2A6 CYP2A13	1.90e-05	2	152	2	7543189
Pubmed	Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha.	TERT PRKCA	1.90e-05	2	152	2	16979586
Pubmed	A developmentally regulated chaperone complex for the endoplasmic reticulum of male haploid germ cells.	CLGN PDILT	1.90e-05	2	152	2	17507649
Pubmed	Characterization and regulation of sex-specific mouse steroid hydroxylase genes.	CYP2A6 CYP2A13	1.90e-05	2	152	2	2372744
Pubmed	VANGL2 protein stability is regulated by integrin αv and the extracellular matrix.	ITGAV VANGL2	1.90e-05	2	152	2	30472097
Pubmed	The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.	CYP2A6 CYP2A7	1.90e-05	2	152	2	2322567
Pubmed	Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.	CYP2A6 CYP2A13	1.90e-05	2	152	2	21473878
Pubmed	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.	KMT2C KMT2D	1.90e-05	2	152	2	27280393
Pubmed	Synaptic and glial localization of the integrin alphavbeta8 in mouse and rat brain.	ITGAV ITGB8	1.90e-05	2	152	2	9593935
Pubmed	The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.	CYP2A6 CYP2A13	1.90e-05	2	152	2	7581481
Pubmed	Expression and alternative splicing of the cytochrome P-450 CYP2A7.	CYP2A6 CYP2A7	1.90e-05	2	152	2	7864805
Pubmed	Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.	CYP2A6 CYP2A13	1.90e-05	2	152	2	28298240
Pubmed	Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate.	ITGAV ITGB8	1.90e-05	2	152	2	31601741
Pubmed	Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice.	CYP2A6 CYP2A13	1.90e-05	2	152	2	6309775
Pubmed	Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.	KMT2C KMT2D	1.90e-05	2	152	2	36869380
Pubmed	Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.	CYP2A6 CYP2A13	1.90e-05	2	152	2	22262919
Pubmed	Cloning and expression of a divergent integrin subunit beta 8.	ITGAV ITGB8	1.90e-05	2	152	2	1918072
Pubmed	Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.	CYP2A6 CYP2A13	1.90e-05	2	152	2	25635819
Pubmed	Cryo-EM structure of the αvβ8 integrin reveals a mechanism for stabilizing integrin extension.	ITGAV ITGB8	1.90e-05	2	152	2	30061598
Pubmed	Genetic variation between mice in their metabolism of coumarin and its derivatives.	CYP2A6 CYP2A13	1.90e-05	2	152	2	566237
Pubmed	Identification and characterization of a 44 kDa protein that binds specifically to the 3'-untranslated region of CYP2a5 mRNA: inducibility, subcellular distribution and possible role in mRNA stabilization.	CYP2A6 CYP2A13	1.90e-05	2	152	2	8611142
Pubmed	Novel causative variants in patients with achromatopsia.	PDE6C CNGA3	1.90e-05	2	152	2	30289319
Pubmed	Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.	KMT2C KMT2D	1.90e-05	2	152	2	25346535
Pubmed	Coumarin toxicity in different strains of mice.	CYP2A6 CYP2A13	1.90e-05	2	152	2	665441
Pubmed	Integrins AV and B8 Gene Polymorphisms and Risk for Intracerebral Hemorrhage in Greek and Polish Populations.	ITGAV ITGB8	1.90e-05	2	152	2	27476161
Pubmed	Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.	TET2 KMT2D	1.90e-05	2	152	2	31311407
Pubmed	The longevity SNP rs2802292 uncovered: HSF1 activates stress-dependent expression of FOXO3 through an intronic enhancer.	FOXO3 HSF1	1.90e-05	2	152	2	29733381
Pubmed	Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene.	CYP2A6 CYP2A13	1.90e-05	2	152	2	24104196
Interaction	CYP2A7 interactions	CYP2A6 CYP2A7 CYP2A13	3.43e-07	3	142	3	int:CYP2A7
Cytoband	11q12.1	OR8J3 OR5B2 SLC43A1 OR8J1 OR5AL1	2.08e-04	161	152	5	11q12.1
GeneFamily	Cytochrome P450 family 2	CYP2A6 CYP2A7 CYP2A13 CYP2R1	4.37e-05	35	102	4	1001
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	TRHDE KANSL1L TCF12 FNDC3A ITGAV KMT2C ADAMTS9 PRKCA LCOR BICC1	5.03e-08	171	148	10	M39234
Coexpression	CHIBA_RESPONSE_TO_TSA_DN	ITGAV BRCA2 ROCK1 MAPK6	5.42e-06	21	148	4	M12459
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	FOXO3 SUPT20H TCF12 TOPBP1 CHD9 TOGARAM1 FNDC3A CEP350 FAM171A1 BRCA2 SEC24B PHLPP1 PRKCA ROCK1 MAPK6 VPS13B TP53BP1	7.25e-06	856	148	17	M4500
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 DOCK8 FNDC3A CEP350 KMT2C GTF3C1 CELSR2 PRKCA	8.80e-06	180	148	8	M8239
Coexpression	GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP	HNF1B NOP56 TMEM237 ZSCAN29 BRCA2 SCN7A SERPINA7	2.18e-05	148	148	7	M1892
Coexpression	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	ABCA2 UPK1A CPT1B CELSR2 BRCA2 MAPK6 EDEM1 OR2AG1	3.61e-05	219	148	8	MM1237
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000	LCORL KMT2C SCML2 ADAMTS9 FNIP1 ROCK1 LCOR	3.48e-06	97	139	7	gudmap_developingGonad_e18.5_epididymis_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500	LCORL SCML2 ADAMTS9 FNIP1 LCOR	1.11e-05	45	139	5	gudmap_developingGonad_e16.5_epididymis_500_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	MPO TBX3 DNAH10 ADAM23 DTNA ITGB8 ZSCAN29 CEP350 LATS1 CELSR2 DCP1B BRCA2 NUP210 PHLPP1 TLE6 ROCK1 RIC3 SEZ6	7.64e-05	983	139	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500	LCORL SCML2 ADAMTS9 FNIP1 LCOR	7.80e-05	67	139	5	gudmap_developingGonad_e18.5_epididymis_500_k3
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_500	LCORL SCML2 ADAMTS9 LCOR	8.80e-05	36	139	4	gudmap_developingGonad_P2_epididymis_500_k3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFAP47 KANSL1L TBX3 ADAM23 PGAP1 PLCL2 PRKCA MGAM2	2.89e-07	190	151	8	078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX3 CLGN DSCAM TERT VANGL2 SCN7A ADGRF5	2.39e-06	176	151	7	7292e014b8f697f0c2e9f47c48333de95cb44a69
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX3 CLGN DSCAM TERT VANGL2 SCN7A ADGRF5	2.39e-06	176	151	7	88ca2f83d8301633232735f39b0683efe49d0b86
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B DOCK8 ITGB8 PARP4 ADAMTS9 BICC1	2.98e-06	182	151	7	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	TBX3 RASGRF2 KALRN ADAMTS9 HECW2 ADGRF5 PLXNA2	4.39e-06	193	151	7	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DSCAM UPK1A ADAM23 CYP2R1 PLD5 SEZ6	1.73e-05	159	151	6	7ed659163f45e0c4df4782997c0786900c8186c8
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRHDE TET2 ITGB8 KMT2C PRKCA MGAM2	2.36e-05	168	151	6	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERF DSCAM DNAH10 UPK1A DNAH1 PLD5	2.44e-05	169	151	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	390C-Endothelial_cells-Endothelial-E-\|390C / Donor, Lineage, Cell class and subclass (all cells)	TBX3 LEPR VANGL2 ADAMTS9 HECW2 ADGRF5	3.26e-05	178	151	6	804ac3725c1f88e2212172bfb9aa01d97a735621
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE CFAP47 DNAH10 DNAI3 DNAH1 SCN7A	3.26e-05	178	151	6	b1db59344c074c7c80169fc2c5cd5fc89f3fe463
ToppCell	390C-Endothelial_cells-Endothelial-E\|390C / Donor, Lineage, Cell class and subclass (all cells)	TBX3 LEPR VANGL2 ADAMTS9 HECW2 ADGRF5	3.26e-05	178	151	6	ad6dc4a375664c919bd48c35c48a561fc5a7de8c
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE CFAP47 DNAH10 DNAI3 DNAH1 SCN7A	3.26e-05	178	151	6	579cdc14f28b459e200ae2102e0bd4df8a2c0dcb
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	TBX3 RASGRF2 KALRN ADAMTS9 HECW2 ADGRF5	3.58e-05	181	151	6	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	KALRN DTNA KCNQ5 ADAMTS9 ROCK1 PLD5	3.81e-05	183	151	6	818fd886e0188091310825f9145fa53328f2c979
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LCORL SLC43A1 AGL SEC24B MAPK6 LCOR	4.05e-05	185	151	6	7925519b855f76444a0b57382ce35d89457b0b14
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CYP2A7 ABCA2 MUC16 FAM171A1 FBXO5	4.30e-05	187	151	6	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	RASGRF2 KALRN ADAM23 FAM171A1 ADAMTS9 HECW2	4.43e-05	188	151	6	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B ITGB8 PARP4 ADAMTS9 BICC1	4.43e-05	188	151	6	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RASGRF2 KALRN ADAMTS9 HECW2 ADGRF5 PLXNA2	4.56e-05	189	151	6	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	TBX3 RASGRF2 ADAMTS9 HECW2 ADGRF5 PLXNA2	4.70e-05	190	151	6	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	RASGRF2 KALRN ADAMTS9 HECW2 ADGRF5 PLXNA2	4.70e-05	190	151	6	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	TBX3 RASGRF2 ADAM23 LEPR FAM171A1 ADAMTS9	4.84e-05	191	151	6	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MPO DNAH10 FBXO5 FAR2 BRCA2 SKA1	5.12e-05	193	151	6	ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO KANSL1L TCF12 KMT2C LIPA EDEM1	5.12e-05	193	151	6	a6a864644e1b80b7417ea0a27281e79068a3fd3d
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	TBX3 RASGRF2 KALRN ADAMTS9 ADGRF5 PLXNA2	5.12e-05	193	151	6	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	RV-09._Endothelium_I\|RV / Chamber and Cluster_Paper	TBX3 RASGRF2 KALRN ADAMTS9 ADGRF5 PLXNA2	5.27e-05	194	151	6	7b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE KANSL1L HNF1B ITGB8 PARP4 BICC1	5.27e-05	194	151	6	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	IPF-Endothelial\|IPF / Disease state, Lineage and Cell class	RASGRF2 KALRN FAM171A1 ADAMTS9 HECW2 ADGRF5	5.27e-05	194	151	6	9591993aa2dcba3d09a0f1ea8b8f2439c26482d6
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MPO DNAH10 FBXO5 FAR2 BRCA2 SKA1	5.27e-05	194	151	6	23318a1b55895b5166c6151f488a94a09b4627ff
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 KALRN LEPR ADGRF5 PLD5 PLXNA2	5.43e-05	195	151	6	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE KANSL1L HNF1B ITGB8 FAM171A1 BICC1	5.43e-05	195	151	6	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	RASGRF2 KALRN ADAMTS9 HECW2 ADGRF5 PLXNA2	5.43e-05	195	151	6	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 KALRN ADAMTS9 HECW2 ADGRF5 PLXNA2	5.58e-05	196	151	6	7cbb19108b4553ef60ef5c230a29de1662c02efe
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	CHD9 CELSR2 PGAP1 ROCK1 PLXNA2 SEZ6	5.58e-05	196	151	6	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	ASK454-Endothelial-Endothelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	TBX3 LEPR VANGL2 ADAMTS9 HECW2 ADGRF5	5.58e-05	196	151	6	2b777a2026b56839112fd179f2db482c49f4594a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RASGRF2 KALRN ADAMTS9 HECW2 ADGRF5 PLXNA2	5.58e-05	196	151	6	4cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	CHD9 CELSR2 PGAP1 ROCK1 PLXNA2 SEZ6	5.58e-05	196	151	6	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DTNA ITGB8 KCNQ5 PLCH2 PLD5 BICC1	5.58e-05	196	151	6	a58bdf9de05d13d84211e09a933679d485bf8ab4
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAM23 LEPR FBXO5 BRCA2 ADAMTS9 SKA1	5.58e-05	196	151	6	eb8c9a4a5eb21d43ff7b25deae5896c236f669b9
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	TCAF2 TBX3 LEPR FAM171A1 HECW2 ADGRF5	5.74e-05	197	151	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE GLT8D2 TBX3 LEPR SCN7A BICC1	5.74e-05	197	151	6	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	RASGRF2 DTNA ITGB8 SCN7A VPS13B BICC1	5.74e-05	197	151	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RASGRF2 KALRN ADAM23 LEPR FAM171A1 ADAMTS9	6.07e-05	199	151	6	e2d5c5cab102e67b0131b02392d81adaedc15965
ToppCell	COVID-19_Severe-immature_Neutrophil\|COVID-19_Severe / Disease condition and Cell class	MPO FBXO5 FAR2 BRCA2 AGL SKA1	6.07e-05	199	151	6	f82fa9d651e78f9ebbe6264e00a48c54b1786a69
ToppCell	COVID-19_Severe-immature_Neutrophil-\|COVID-19_Severe / Disease condition and Cell class	MPO FBXO5 FAR2 BRCA2 AGL SKA1	6.07e-05	199	151	6	42ea0c19c455bdb0ae89b428d09c333104c670dc
ToppCell	Parenchyma_COVID-19-Endothelial-TX\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	ADAM23 LEPR FAM171A1 ADAMTS9 HECW2 ADGRF5	6.24e-05	200	151	6	abcbd5a156aa4fd51d284441388975c81c0b88ae
ToppCell	Lung_Parenchyma-Severe-Endothelial\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADAM23 LEPR FAM171A1 ADAMTS9 HECW2 ADGRF5	6.24e-05	200	151	6	d9d0ffa18e5b4647966e19ad9830cbba6120677e
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RASGRF2 DOCK8 ADAM23 JAK3 NUP210 PLCL2	6.24e-05	200	151	6	e0cec0a844b7c1f8edee4c005af27766754e470a
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADAM23 LEPR FAM171A1 ADAMTS9 HECW2 ADGRF5	6.24e-05	200	151	6	e9d5ba140cabae11c437012d519b85f5412dcc94
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GLT8D2 TBX3 ITGB8 LEPR SCN7A BICC1	6.24e-05	200	151	6	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HNF1B DNAH10 ASTL JAK3 RIC3	6.51e-05	124	151	5	a7b7d8b14d1218194da8fcf69b4780b6e9469332
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma-7\|TCGA-Lung / Sample_Type by Project: Shred V9	SI CLRN3 SCN7A PRKCA ADGRF5	8.14e-05	130	151	5	0219d0d5d21df08f816569c7eb34f1bfa095d29a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	OR8J3 ASTL DNAH1 PLCH2 ADGRF5	9.73e-05	135	151	5	b444005987093efab3265201b3541d7941816cc2
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KALRN DOCK8 DNAH1 JAK3 PLCL2	1.64e-04	151	151	5	b698ddc74565d47892c09c3f16d78038da2dd5e7
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	CFAP47 CYP2A13 DNAH10 MUC16 CAPN13	1.64e-04	151	151	5	8216462e723fec2797387929dde095370947e10a
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 PDK4 DCST1 SCN7A SKA1	1.70e-04	152	151	5	621e9b33cd3bb1c7b7d0633069f286b203e3d9c0
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX3 DSCAM TERT SCN7A BICC1	1.80e-04	154	151	5	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 VANGL2 CAPN13 PLXNA2	1.97e-04	157	151	5	6ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE DNAH10 DTNA PTPRQ PLD5	2.15e-04	160	151	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE DNAH10 DTNA PTPRQ PLD5	2.15e-04	160	151	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	390C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNHD1 TBX3 LEPR VANGL2 ADGRF5	2.28e-04	162	151	5	45be019b50e3727fc9d3fad2ff78e74e4f2d746b
ToppCell	390C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNHD1 TBX3 LEPR VANGL2 ADGRF5	2.28e-04	162	151	5	fbb0cc2b1434a340dc35058b77c73ea61004c252
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B PARP4 ADAMTS9 BICC1	2.41e-04	164	151	5	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B ITGB8 ADAMTS9 BICC1	2.41e-04	164	151	5	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	Endothelial-endothelial_cell_of_bronchial_vessel\|World / Lineage, Cell type, age group and donor	RASGRF2 KALRN LEPR ADAMTS9 HECW2	2.48e-04	165	151	5	84e553d699ac56df89a77248f7308b9133e1b683
ToppCell	356C-Fibroblasts-Fibroblast-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 ADAM23 LEPR SCN7A FBXO39	2.55e-04	166	151	5	7286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell	356C-Fibroblasts-Fibroblast-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	GLT8D2 ADAM23 LEPR SCN7A FBXO39	2.55e-04	166	151	5	7c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNF1B UPK1A MUC16 ZNF217 ASTL	2.62e-04	167	151	5	720dc5855c856b478b5ca90156b30bfcc5518d60
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TBX3 APOF LEPR ADAMTS9 BICC1	2.70e-04	168	151	5	9930bd63b60c03f0152838a79eef77da1c2dd8e5
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLT8D2 KALRN ACAD10 LIPA C1orf105	2.70e-04	168	151	5	e979a4fbeb9f21048b47d69e6da75c57650697f2
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DNAH10 SLC43A1 APOF PDILT	2.71e-04	92	151	4	d2c1d25e5bb6ba4f406e916e3c0a5ad05492e59d
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DNAH10 SLC43A1 APOF PDILT	2.71e-04	92	151	4	926e02725a03d8473eda25d4aef63e34a6566224
ToppCell	Ionocyte-iono-1\|World / Class top	DTNA AGL PDILT PLCL2 ADGRF5	2.77e-04	169	151	5	4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	DNHD1 RASGRF2 HECW2 ADGRF5	2.82e-04	93	151	4	d108fce6bc55e76ba1861ab601bffca29b85b8fa
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D122\|Adult / Lineage, Cell type, age group and donor	KALRN ADAM23 FAM171A1 ADAMTS9 HECW2	2.85e-04	170	151	5	a99cb3d21f8eb926886340ea99491e078e607648
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	KALRN PARP4 PLCL2 PLD5 SKA1	2.85e-04	170	151	5	09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	TBX3 UPK1A KALRN HECW2 PLXNA2	2.93e-04	171	151	5	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	metastatic_Brain-B_lymphocytes-Undetermined\|B_lymphocytes / Location, Cell class and cell subclass	TCAF2 VPS37A ERF TOPBP1 KCNQ5	2.93e-04	171	151	5	0d14bc9688c427ba2265984987dc3eea195b19eb
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)--\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DNHD1 HNF1B PDK4 C1orf105	2.94e-04	94	151	4	c73e99890431750b74f984de5c82e33533ab708b
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DNHD1 HNF1B PDK4 C1orf105	2.94e-04	94	151	4	1bda61101f45f5c4a68453087b880fdc6d9acfca
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DNHD1 HNF1B PDK4 C1orf105	2.94e-04	94	151	4	9664f74bc0168c92fb8a68cad628323c476f6103
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ITGB8 PTP4A1 ADAMTS9 BICC1	3.01e-04	172	151	5	0c2d0bb767e5ce089b42ad49e8b303a103de2d5c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ITGB8 PTP4A1 ADAMTS9 BICC1	3.01e-04	172	151	5	eeed177a03c116e9815a8e086d24efc9643b16a4
ToppCell	Control-Endothelial_cells-Systemic_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	RASGRF2 KALRN ADAM23 FAM171A1 ADAMTS9	3.01e-04	172	151	5	c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCell	TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	MPO CYP2A13 DNAH10 MUC16 DNAI3	3.01e-04	172	151	5	6b8a8d3b97c10b9d092307eed3cacbd2745df185
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCAF2 FAM171A1 FAR2 HECW2 ADGRF5	3.01e-04	172	151	5	c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Pdyn_(MGE-derived_cortical_interneurons--Martinotti_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CLRN3 C1orf105 FBXO39	3.10e-04	39	151	3	66fe368f1dfe665c661cf9baf854d12eb28c25b8
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Pdyn_(MGE-derived_cortical_interneurons--Martinotti_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CLRN3 C1orf105 FBXO39	3.10e-04	39	151	3	d5b0bcdfb27c881049178079c48deb587a0b2fda
ToppCell	Club-club-15\|World / Class top	HNF1B ERF FAR2 CYP2R1 SKA1	3.25e-04	175	151	5	ca9d012f520f697c7450ec6958a015e20538a6a8
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLGN TCF12 DSCAM KCNQ5 RIC3	3.25e-04	175	151	5	2ce8bcf9926862e723219b4246388428d0c3fdee
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B PARP4 ADAMTS9 BICC1	3.34e-04	176	151	5	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLGN TCF12 DSCAM KCNQ5 RIC3	3.43e-04	177	151	5	d1dd778d1a52305b1ea3954f81fd5364b3d57bbe
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RASGRF2 ADAMTS9 HECW2 ADGRF5 PLXNA2	3.70e-04	180	151	5	755050226eeb1991ee7f0d15e39d0458f3e4a791
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUPT20H UPK1A SLC43A1 KCNQ5 PRKCA	3.70e-04	180	151	5	c12c1cc206f7e63e5722471bd3eb84caddb84129
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUPT20H UPK1A SLC43A1 KCNQ5 PRKCA	3.70e-04	180	151	5	d8135f73a89b97168f2048258f4648e23536ece4
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRF2 ADAM23 FAM171A1 HECW2 ADGRF5	3.80e-04	181	151	5	4df7972f88117108698efd06b124b232f8588981
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	TBX3 KALRN HECW2 ADGRF5 PLXNA2	3.80e-04	181	151	5	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE HNF1B DOCK8 ITGB8 BICC1	3.80e-04	181	151	5	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRF2 ADAM23 FAM171A1 HECW2 ADGRF5	3.80e-04	181	151	5	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK8 CHD9 CEP350 PGAP1 NIN	3.89e-04	182	151	5	f8c73baaaca145e2efc48f10f636feb79c8fc779
Drug	2'-methoxyacetophenone	CYP2A6 CYP2A7 CYP2A13	2.64e-07	3	147	3	CID000068481
Disease	esophagus squamous cell carcinoma (is_implicated_in)	TET2 TERT KMT2C KMT2D BRCA2	2.88e-06	45	146	5	DOID:3748 (is_implicated_in)
Disease	neutrophil count, eosinophil count	MPO TET2 RPN1 DOCK8 TERT LEPR THADA LIPA	1.16e-05	213	146	8	EFO_0004833, EFO_0004842
Disease	Streptozotocin Diabetes	MPO FOXO3 PDK4 CPT1B LEPR PRKCA	1.67e-05	108	146	6	C0038433
Disease	Diabetes Mellitus, Experimental	MPO FOXO3 PDK4 CPT1B LEPR PRKCA	1.67e-05	108	146	6	C0011853
Disease	Alloxan Diabetes	MPO FOXO3 PDK4 CPT1B LEPR PRKCA	1.67e-05	108	146	6	C0002152
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	2.43e-05	2	146	2	DOID:0080598 (implicated_via_orthology)
Disease	neutrophil percentage of leukocytes	MPO TET2 KALRN RPN1 DOCK8 TERT ZBTB1 LEPR THADA LIPA GTF3C1 PTCD1	5.45e-05	610	146	12	EFO_0007990
Disease	adhesion G protein-coupled receptor F5 measurement	RHCE ADGRF5	7.27e-05	3	146	2	EFO_0801346
Disease	hepatocellular clear cell carcinoma (is_marker_for)	TERT LEPR	7.27e-05	3	146	2	DOID:5016 (is_marker_for)
Disease	serum alanine aminotransferase measurement	FOXO3 CYP2A6 HNF1B LCORL SLC43A1 LEPR CDH20 CELSR2 ADAMTS9 NUP210 PRKCA DYNLRB1 CNOT1 NIN	1.10e-04	869	146	14	EFO_0004735
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	TET2 HNF1B TERT BRCA2	1.29e-04	52	146	4	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	neutrophil count, basophil count	MPO TET2 RPN1 DOCK8 TERT LEPR THADA	1.31e-04	224	146	7	EFO_0004833, EFO_0005090
Disease	Achromatopsia	PDE6C CNGA3	2.41e-04	5	146	2	cv:C0152200
Disease	granulocyte count	MPO TET2 RPN1 DOCK8 TERT LEPR THADA	2.83e-04	254	146	7	EFO_0007987
Disease	myeloperoxidase measurement	MPO RPN1 THADA	2.84e-04	26	146	3	EFO_0005243
Disease	Sezary Syndrome	TET2 KMT2C KMT2D	3.18e-04	27	146	3	C0036920
Disease	lymphocyte percentage of leukocytes	MPO TET2 RPN1 TERT LEPR THADA LIPA GTF3C1 PTCD1 ZBTB25 PLCL2	4.93e-04	665	146	11	EFO_0007993
Disease	Achromatopsia	PDE6C CNGA3	5.02e-04	7	146	2	C0152200
Disease	Joubert syndrome (implicated_via_orthology)	TMEM237 TOGARAM1	5.02e-04	7	146	2	DOID:0050777 (implicated_via_orthology)
Disease	Craniosynostosis syndrome	TCF12 ERF	5.02e-04	7	146	2	cv:C0010278
Disease	response to aromatase inhibitor	CYP2A6 MUC16 CNOT1	5.30e-04	32	146	3	GO_0061477
Disease	lower urinary tract symptom, benign prostatic hyperplasia	TBX3 HNF1B TERT	5.30e-04	32	146	3	EFO_0000284, EFO_0008008
Disease	non-small cell lung carcinoma	CYP2A6 DSCAM TERT BRCA2	5.32e-04	75	146	4	EFO_0003060
Disease	Malignant neoplasm of urinary bladder	MPO TERT KMT2C KMT2D BRCA2	6.98e-04	141	146	5	C0005684
Disease	Liver Diseases, Parasitic	CYP2A6 KMT2C	8.56e-04	9	146	2	C0023897
Disease	platelet measurement	TCF12 KALRN DOCK8 CHD9 ACAD10 TERT FAR2	1.01e-03	315	146	7	EFO_0005036
Disease	Prostatic Neoplasms	MPO TET2 CYP2A6 TBX3 HNF1B ERF TERT KMT2C KMT2D BRCA2	1.02e-03	616	146	10	C0033578
Disease	Malignant neoplasm of prostate	MPO TET2 CYP2A6 TBX3 HNF1B ERF TERT KMT2C KMT2D BRCA2	1.02e-03	616	146	10	C0376358
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN7A SCN10A	1.07e-03	10	146	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN7A SCN10A	1.07e-03	10	146	2	DOID:0080422 (implicated_via_orthology)
Disease	Joubert syndrome (is_implicated_in)	TMEM237 TOGARAM1	1.07e-03	10	146	2	DOID:0050777 (is_implicated_in)
Disease	prostate cancer (is_marker_for)	FOXO3 TERT KMT2C KMT2D PHLPP1	1.10e-03	156	146	5	DOID:10283 (is_marker_for)
Disease	nucleus accumbens volume change measurement	DSCAM MUC16	1.30e-03	11	146	2	EFO_0021493
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	CYP2A6 DNAH10 CELSR2 BRCA2 TP53BP1	1.45e-03	166	146	5	EFO_0004530, EFO_0004611
Disease	QRS complex, QRS duration	TKT SCN10A PRKCA	1.45e-03	45	146	3	EFO_0005054, EFO_0005055
Disease	fibrinogen measurement, tissue plasminogen activator measurement	CHD9 LEPR FNIP1	1.45e-03	45	146	3	EFO_0004623, EFO_0004791
Disease	nicotine metabolite ratio	CYP2A6 CYP2A7	1.55e-03	12	146	2	EFO_0007794
Disease	craniosynostosis (is_implicated_in)	TCF12 ERF	1.55e-03	12	146	2	DOID:2340 (is_implicated_in)
Disease	chronic kidney disease (implicated_via_orthology)	TERT LEPR	1.55e-03	12	146	2	DOID:784 (implicated_via_orthology)
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN7A SCN10A	1.55e-03	12	146	2	DOID:0060170 (implicated_via_orthology)
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	LATS1 BICC1	2.13e-03	14	146	2	DOID:898 (implicated_via_orthology)
Disease	triacylglycerol 48:4 measurement	DSCAM PLD5	2.13e-03	14	146	2	EFO_0010407
Disease	fibrinogen measurement	CHD9 ACAD10 LEPR LIPA	2.14e-03	109	146	4	EFO_0004623
Disease	granulocyte percentage of myeloid white cells	MPO RPN1 DOCK8 CHD9 LEPR THADA	2.23e-03	268	146	6	EFO_0007997
Disease	triglyceride measurement, intermediate density lipoprotein measurement	DNAH10 CELSR2 BRCA2 TP53BP1	2.29e-03	111	146	4	EFO_0004530, EFO_0008595
Disease	myeloid white cell count	MPO TET2 ERF DNAH10 RPN1 DOCK8 TERT LEPR THADA LIPA GTF3C1 ADGRF5	2.47e-03	937	146	12	EFO_0007988
Disease	low density lipoprotein cholesterol measurement, lipid measurement	CYP2A6 LEPR CELSR2 BRCA2	2.52e-03	114	146	4	EFO_0004529, EFO_0004611
Disease	triglycerides in medium VLDL measurement	DNAH10 CELSR2 TP53BP1	2.58e-03	55	146	3	EFO_0022155
Disease	Colorectal Carcinoma	MPO TET2 CYP2A6 RASGRF2 KALRN ZNF217 KMT2C KCNQ5 PDILT RIC3	2.67e-03	702	146	10	C0009402
Disease	ovarian cancer (is_implicated_in)	MUC16 BRCA2 PRKCA	2.72e-03	56	146	3	DOID:2394 (is_implicated_in)
Disease	Inherited oocyte maturation defect	ASTL TLE6	2.79e-03	16	146	2	cv:CN238505
Disease	Synostotic Posterior Plagiocephaly	TCF12 ERF	2.79e-03	16	146	2	C1833340
Disease	Craniosynostosis, Type 1	TCF12 ERF	2.79e-03	16	146	2	C4551902
Disease	Acrocephaly	TCF12 ERF	2.79e-03	16	146	2	C0030044
Disease	Trigonocephaly	TCF12 ERF	2.79e-03	16	146	2	C0265535
Disease	Scaphycephaly	TCF12 ERF	2.79e-03	16	146	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	TCF12 ERF	2.79e-03	16	146	2	C2931150
Disease	Metopic synostosis	TCF12 ERF	2.79e-03	16	146	2	C1860819
Disease	Inborn Errors of Metabolism	LEPR SERPINA7	3.15e-03	17	146	2	C0025521
Disease	Brachycephaly	TCF12 ERF	3.15e-03	17	146	2	C0221356
Disease	IGF-1 measurement, IGFBP-3 measurement	FOXO3 CELSR2	3.15e-03	17	146	2	EFO_0004626, EFO_0004627
Disease	mean corpuscular hemoglobin concentration	KALRN RPN1 ZNF217 ACAD10 TERT OR6P1 LEPR RHCE HECW2 C1orf105 PLCL2 ADGRF5 VPS13B	3.42e-03	1105	146	13	EFO_0004528
Disease	Brugada syndrome	SCN10A PRKCA	3.93e-03	19	146	2	MONDO_0015263
Disease	cardiomyopathy (is_implicated_in)	DTNA SRF	3.93e-03	19	146	2	DOID:0050700 (is_implicated_in)
Disease	caffeine metabolite measurement	CYP2A6 CYP2A7	3.93e-03	19	146	2	EFO_0007872
Disease	cystatin C measurement	KALRN FNDC3A ACAD10 DCST1 DNAH1 PDILT FNIP1	3.98e-03	402	146	7	EFO_0004617
Disease	creatinine measurement	FOXO3 TET2 SLC52A1 TCF12 DSCAM CHD9 ACAD10 CDH20 CELSR2 PDILT FNIP1 RIC3	4.01e-03	995	146	12	EFO_0004518
Disease	cholesterol in large VLDL measurement	DNAH10 CELSR2 TP53BP1	4.14e-03	65	146	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	DNAH10 CELSR2 TP53BP1	4.14e-03	65	146	3	EFO_0022230
Disease	Craniosynostosis	TCF12 ERF	4.36e-03	20	146	2	C0010278
Disease	obesity (implicated_via_orthology)	TCF12 DNAH10 LEPR THADA ADAMTS9	4.41e-03	215	146	5	DOID:9970 (implicated_via_orthology)
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	CYP2A6 DNAH10 RHCE CELSR2 TP53BP1	4.41e-03	215	146	5	EFO_0008317, EFO_0008591
Disease	platelet component distribution width	FOXO3 SUPT20H KALRN RPN1 DOCK8 HEATR4 RHCE FAR2 C1orf105 ADGRF5	4.45e-03	755	146	10	EFO_0007984
Disease	ovarian neoplasm	MUC16 TERT BRCA2 TP53BP1	4.49e-03	134	146	4	C0919267
Disease	tuberculosis	CYP2A6 DSCAM LIPA PLD5 VPS13B	4.50e-03	216	146	5	MONDO_0018076
Disease	total lipids in small VLDL	DNAH10 CELSR2 TP53BP1	4.51e-03	67	146	3	EFO_0022148
Disease	total lipids in large VLDL	DNAH10 CELSR2 TP53BP1	4.51e-03	67	146	3	EFO_0022175
Disease	Benign Neoplasm	SRF TERT HSF1	4.70e-03	68	146	3	C0086692
Disease	Neoplasms	SRF TERT HSF1	4.70e-03	68	146	3	C0027651
Disease	free cholesterol in large VLDL measurement	DNAH10 CELSR2 TP53BP1	4.70e-03	68	146	3	EFO_0022265
Disease	Malignant neoplasm of ovary	MUC16 TERT BRCA2 TP53BP1	4.86e-03	137	146	4	C1140680
Disease	mean platelet volume	TET2 TCF12 KALRN RPN1 DOCK8 CHD9 ZNF217 TERT LEPR FAR2 ADGRF5 NIN	4.87e-03	1020	146	12	EFO_0004584
Disease	congenital heart disease (implicated_via_orthology)	CHD9 KMT2C KMT2D	4.90e-03	69	146	3	DOID:1682 (implicated_via_orthology)
Disease	Prostate cancer, familial	HNF1B ITGB8 BRCA2	4.90e-03	69	146	3	C2931456

Protein segments in the cluster

Peptide	Gene	Start	Entry
LRTTKQQPYHTMESI	VANGL2	406	Q9ULK5
SIKHQATYLSLSNMP	TRHDE	291	Q9UKU6
NYSTMDPVQKAVLSH	ZNF385A	46	Q96PM9
SPEDMKRYLQAHTQS	ERF	306	P50548
ITTNPVQMLHEFSKY	ADAM23	361	O75077
KHVGFATIPRNYTMS	CYP2A6	476	P11509
ATSYGKQTNVLMHFP	APOF	36	Q13790
MFRKIHSIFNSSPQR	C13orf42	1	A0A1B0GVH6
KEMPFTNPLTRSYHT	ACAD10	606	Q6JQN1
KSSTSRPDAYEHTQM	BCAP29	81	Q9UHQ4
PQYRQKILMVQSFSH	CAPN13	106	Q6MZZ7
SALAQNMRHTYLSPF	CELSR2	2146	Q9HCU4
NTYAPTMPFKHSQAT	DNHD1	4071	Q96M86
NPTTTQYASLMHSFI	DYNLRB1	36	Q9NP97
LSRPSTNEMASVNHY	DNAI3	796	Q8IWG1
RRANHVSYKPTMTTT	BICC1	776	Q9H694
INFTMPNTIKHYVHR	DDX27	536	Q96GQ7
INFIKSQSSNMLTPY	ASTL	216	Q6HA08
QINKFLYLHTSERMP	ATG2A	1536	Q2TAZ0
SLNRKYTPVSYMHTA	INTS7	761	Q9NVH2
YQLSQMTFHKIPADS	JAK3	506	P52333
HFSRYSPSPLSMKQL	PDK4	26	Q16654
FTVLHSNPSAYRMFT	HECW2	931	Q9P2P5
YLRVSMSPVLHTQNK	NUP210	1376	Q8TEM1
RPKSTLVYHITSGNM	FAR2	296	Q96K12
LYVNGFTHRSSMPTT	MUC16	12186	Q8WXI7
LHTYLRSKMSQVAPS	NOP56	281	O00567
HTPMLKLSYSTSQEF	FAM171A1	411	Q5VUB5
PQSSKHYQTVFLMRS	KANSL1L	71	A0AUZ9
QNYSMPTSSFRNLLK	PRAMEF17	186	Q5VTA0
QSPMRETPSKAFHQY	KMT2C	4266	Q8NEZ4
LRRQFISYTKMHPNN	KTI12	321	Q96EK9
HTATMLQVKIYDPTN	MGAM2	1001	Q2M2H8
KTFPASNYTVSSRQM	LATS1	16	O95835
VHMYDTVSQIKSPFT	HIPK1	546	Q86Z02
PKNLNMSRLDVYFSH	LIPJ	236	Q5W064
TSNFDRYVHATKMQP	KIAA1109	1786	Q2LD37
RYVHATKMQPQSSGS	KIAA1109	1791	Q2LD37
TFYALSPTMHSQATQ	KCNQ5	701	Q9NR82
PTASTYLHQLTLQKM	LCORL	376	Q8N3X6
YTHVTTMGQRLSQKA	SLC43A1	251	O75387
SMPKYSRQFSLEHVH	HSF1	221	Q00613
FMTKSHQQYTFVNPS	PLXNA2	941	O75051
MSVSKAQSIYGIPHS	LCOR	366	Q96JN0
AMKSSPQIPHQTYSS	MAPK6	701	Q16659
HSPTQDKMVSVFYTI	OR2M2	266	Q96R28
IYLQPSSSHSMDTDK	OR5B2	256	Q96R09
TVSKNNIFMSNSYPR	MPO	711	P05164
HRGTNNLYQMKSTSP	PDE6C	606	P51160
YNSPQFKKTMSTFHN	FBXO39	211	Q8N4B4
SPSYENSLHSLQSRM	TCF12	386	Q99081
FLKYIHRNNVSMPSV	KALRN	1076	O60229
YMPQFQTCSTQTHKI	LEPR	1141	P48357
SPMLIVFHGKYSTIN	GLT8D2	271	Q9H1C3
YTAMPGNTHRKITSF	RIC3	131	Q7Z5B4
TFMYVLPSSFHSTRQ	OR2AG1	256	Q9H205
SYPKHITSNTMAAEF	PARP4	926	Q9UKK3
LFMYLQPQTNHSLDT	OR8J3	256	Q8NGG0
RNSTKVSPQDHMYTF	PTPRQ	1421	Q9UMZ3
NNVYVKSTTMEHPSL	ITGB8	311	P26012
LFMYVQPRSNHSLDT	OR8J1	256	Q8NGP2
RPRAMYTFNHNKIIS	OR6P1	261	Q8NGX9
VYTRSASPKHGFTIM	DCP1B	61	Q8IZD4
NTVTPRLMRHFNYLS	DNAH1	2351	Q9P2D7
KSPQHVMAPTLNFYT	ADAMTS9	456	Q9P2N4
YSQSKMAHSRTSTPL	CHD9	2001	Q3L8U1
KHVGFATIPRNYTMS	CYP2A13	476	Q16696
NTVLTTMHAFPYIKT	DOCK8	1916	Q8NF50
PFYQVSATRNEKMRH	BRCA2	2381	P51587
NNKFSPHASTREYVM	FBXO5	306	Q9UKT4
QAPASRLHLSTQKMY	DCST1	226	Q5T197
QKHYQMSVLESAPIS	CDH20	276	Q9HBT6
KHVVFATIPRNYTMS	CYP2A7	476	P20853
AASSELPHVYMRKQS	CYP2R1	56	Q6VVX0
PKTLSTDSIQYHLQM	FNDC3A	976	Q9Y2H6
SSQSVDMLAKTHPYN	FNIP1	486	Q8TF40
ALFLYSRSPSHSKNM	ITGAV	541	P06756
VPMVFFSSQYRLHRK	HEATR4	46	Q86WZ0
FQTMSSVTNLTPHYF	GALNTL5	151	Q7Z4T8
TRKNHNMASRPLTFT	CEP350	781	Q5VT06
NHPMNKTSASLSLDY	ABCA2	1771	Q9BZC7
NPVHKSGTRYMFTTE	EDEM1	566	Q92611
STIFYQLNKRMPTTH	DTNA	86	Q9Y4J8
RSVSEKNSYHPVSLM	FAM161A	141	Q3B820
KNSYHPVSLMTSFSE	FAM161A	146	Q3B820
KLQNTFRTPVYTTSM	DNAH10	4421	Q8IVF4
YTNFASIPQKMTHLP	SEC24B	1186	O95487
LIESHFINMYTRPKS	CFAP47	1806	Q6ZTR5
SRHPMLYSFQTSLPK	CPT1B	161	Q92523
SKRQSHKYQAEFPMS	LILRA3	371	Q8N6C8
QPLHTYSMKDSVATV	OR1D4	261	P47884
QPLHTYSMKDSVATV	OR1D5	261	P58170
QYSHTSRFPSAMVVT	HNF1B	521	P35680
RFLMVLFHNPSSKQS	PDILT	61	Q8N807
HPSSTYSIRMYAKNR	DSCAM	951	O60469
RMEFPSYTINRKTHI	FAN1	581	Q9Y2M0
IQENKPATFSSMSHY	FOXO3	451	O43524
LVTFSTLYNKMHGTP	RUSC2	281	Q8N2Y8
KVSQFPELTSHTMRF	RUSC2	1091	Q8N2Y8
PLHYTTKMTNSTIKQ	TAAR3P	136	Q9P1P4
PSVSLQQYKNFMSSI	THADA	721	Q6YHU6
FGTQTILNSMHKYQP	TBX3	236	O15119
QPKKSMNSVTRNLYH	SKA1	181	Q96BD8
NHTFPRLNRNKYMVT	PLD5	431	Q8N7P1
TPEMRSYHFRKALSQ	TCAF2	406	A6NFQ2
LFQSIMEHNVSYPKS	PRKCA	546	P17252
SASTPYRQLKRHLSM	NIN	256	Q8N4C6
KNERTPYIMKTSQHF	RASGRF2	1036	O14827
IIFMYPQPKSSHSLN	OR5AL1	271	P0C617
QDMKQPLSHYFINSS	PLCL2	426	Q9UPR0
VHYENNSPFLTITSM	RPN1	216	P04843
PENNTHVALFKMYTS	PGAP1	556	Q75T13
PAQNTFYSRQKHMKL	SI	1696	P14410
KPSQLQSQFRLTYTM	SKIV2L	736	Q15477
TGHVYTFATRKLQPM	SRF	191	P11831
FNTPAMHIAYQSRLS	ACTL7A	191	Q9Y615
MVIKSSHPETYQQRF	ADGRF5	856	Q8IZF2
MSYRMSLHQPKFQTT	C1orf105	111	O95561
FTDRKTHLYTLVMNP	CLGN	221	O14967
FTVSSVVPHNFMYSK	CLEC4C	36	Q8WTT0
FQMLYPATTSKGTTH	CLRN3	161	Q8NCR9
MAKINTQYSHPSRTH	CNGA3	1	Q16281
YDTSYNNKMPLSTHR	C11orf1	101	Q9H5F2
MKRVSIEPNFHSLYS	CNOT1	1136	A5YKK6
YLSHIATEMNQVFSP	ZBTB25	106	P24278
QQMTSDRIHLYTPSS	TMEM237	326	Q96Q45
SSLAHPQRKISMTYV	RHCE	256	P18577
PQRKISMTYVHSAVL	RHCE	261	P18577
LFFHTMRYKSQDPRN	TKT	51	P29401
MFPPTSIYHVFQSRK	SLC52A1	426	Q9NWF4
NPMYIHTSVSQDFSR	SCML2	561	Q9UQR0
MAVNETTNYSSHRKP	SCN10A	281	Q9Y5Y9
QDMTQPLSHYFITSS	PLCH2	326	O75038
SSNMKSPGYQSRHIL	SUPT20H	151	Q8NEM7
HSSQPNATLYKMSSI	SERPINA7	31	P05543
QYSGPRSHFKLFTSM	SEZ6	661	Q53EL9
EYSQSPKMESLSSHR	TP53BP1	521	Q12888
THRDYMVSNPSLITK	UPK1A	116	O00322
TYSKIMNHKNSLTFP	ROCK1	286	Q13464
HSTISLPFKYMQQCT	ZNF844	566	Q08AG5
MNVKSVTKHSYLPRS	ZNF844	586	Q08AG5
MAKPSHSSYVLQQLN	ZBTB1	1	Q9Y2K1
KVFSYNSSLMVHQRT	ZNF852	446	Q6ZMS4
TRLHFTYENLNSKMP	VPS13B	236	Q7Z7G8
PVSYQHLSNSMAQKR	ZNF217	1016	O75362
LHMAYNRLQSFPASK	PHLPP1	1041	O60346
FLTLEHYPMSKQTNT	SCN7A	521	Q01118
AISQYKERMPSVTHS	TOGARAM1	1226	Q9Y4F4
YSKSFGPNSLLMHQV	ZSCAN29	656	Q8IWY8
TDMKKSQVTPNTHIY	PTCD1	576	O75127
RSMEVKPAQASHTNY	GTF3C1	1631	Q12789
RISLVFYQHKSMNEP	TET2	1896	Q6N021
HTYNPKMSLDISAVQ	TOPBP1	991	Q92547
EVTYKNMRFLITHNP	PTP4A1	11	Q93096
SHVSTLTDLQPYMRQ	TERT	761	O14746
VYVTSPLVNNFTMHS	VPS37A	96	Q8NEZ2
EYQFKSQIMSLSHSP	TLE6	456	Q9H808
KESGYNMIHFTPLQT	AGL	151	P35573
RPHTLNSTSMSKAYQ	KMT2D	5351	O14686
NLNMSRVDVYTTHSP	LIPA	271	P38571